Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jac5.1422 http://scihub22266oqcxt.onion/10.1002/jac5.1422 34230911!8250635!34230911     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34230911&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Am+Coll+Clin+Pharm 2021 ; 4 (8): 964-968 Nephropedia Template TP {{tp|p=34230911|t=2021. Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care |pdf=|usr=}}{{34230911}} gab.com Text Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care JO: J Am Coll Clin Pharm http://www.kidney.de/pget.php?&tw=1&pmid=34230911 #FOAvip INTRODUCTION: The Coronavirus Disease 2019 (COVID-19) pandemic has presented social distancing challenges leading healthcare systems to adapt and utilize telemedicine platforms more than ever before. Reducing patient exposure to COVID-19 became a primary concern, especially for populations at an increased risk for severe illness, such as human immunodeficiency virus (HIV) positive patients. OBJECTIVES: The primary objective of this study was to measure the impact of pharmacy services including telehealth through the percentage of virologically suppressed patients (HIV ribonucleic acid [RNA] < 200 copies/mL) during the pre-COVID and post-COVID time periods. Secondary objectives included the percentage of patients with undetectable viral loads (HIV RNA < 20 copies/mL), percentage of patients with cluster of differentiation 4 (CD4) cell counts greater than 200 cells/mm(3), and changes in CD4 cell counts and percentages pre-COVID and post-COVID. METHODS: This was a retrospective chart review at a single center HIV primary care clinic in Brooklyn, NY evaluating electronic medical records (EMRs) of 211 HIV-positive patients. Pre-COVID was defined as 1 year prior to March 13, 2020, and post-COVID was defined as March 13 to July 20, 2020. RESULTS: Viral load suppression rates for pre and post-COVID were 88.6% and 85.3%, respectively (P = .28). Undetectable viral load rates for pre and post-COVID were approximately 81.5% and 74.4% (P = .096). Mean CD4 cell counts and percentages were 617 cells/mm(3) and 29% for pre-COVID, and 460 cells/mm(3) and 22% for post-COVID. CD4 cell counts greater than 200 cells/mm(3) pre-COVID and post-COVID was 92.6% and 78.3%, respectively (P = .001). CONCLUSION: Utilization of pharmacy services including telehealth, may allow clinical pharmacists to collaboratively provide remote services without jeopardizing patient outcomes. Larger studies are needed to confirm these findings, and display the long-term impact and satisfaction of these services. Twit Text FOAVip Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care ????J Am Coll Clin Pharm http://www.kidney.de/pget.php?&tw=1&pmid=34230911 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34230911 #FOAvip English Wikipedia <ref>{{Cite pmid|34230911}}</ref> Evaluation of virologic suppression rates during the COVID-19 pandemic with outpatient interdisciplinary HIV care #MMPMID34230911 Sorbera M; Fischetti B; Khaimova R; Niewinski M; Wen K J Am Coll Clin Pharm 2021[Aug]; 4 (8): 964-968 PMID34230911show ga INTRODUCTION: The Coronavirus Disease 2019 (COVID-19) pandemic has presented social distancing challenges leading healthcare systems to adapt and utilize telemedicine platforms more than ever before. Reducing patient exposure to COVID-19 became a primary concern, especially for populations at an increased risk for severe illness, such as human immunodeficiency virus (HIV) positive patients. OBJECTIVES: The primary objective of this study was to measure the impact of pharmacy services including telehealth through the percentage of virologically suppressed patients (HIV ribonucleic acid [RNA] < 200 copies/mL) during the pre-COVID and post-COVID time periods. Secondary objectives included the percentage of patients with undetectable viral loads (HIV RNA < 20 copies/mL), percentage of patients with cluster of differentiation 4 (CD4) cell counts greater than 200 cells/mm(3), and changes in CD4 cell counts and percentages pre-COVID and post-COVID. METHODS: This was a retrospective chart review at a single center HIV primary care clinic in Brooklyn, NY evaluating electronic medical records (EMRs) of 211 HIV-positive patients. Pre-COVID was defined as 1 year prior to March 13, 2020, and post-COVID was defined as March 13 to July 20, 2020. RESULTS: Viral load suppression rates for pre and post-COVID were 88.6% and 85.3%, respectively (P = .28). Undetectable viral load rates for pre and post-COVID were approximately 81.5% and 74.4% (P = .096). Mean CD4 cell counts and percentages were 617 cells/mm(3) and 29% for pre-COVID, and 460 cells/mm(3) and 22% for post-COVID. CD4 cell counts greater than 200 cells/mm(3) pre-COVID and post-COVID was 92.6% and 78.3%, respectively (P = .001). CONCLUSION: Utilization of pharmacy services including telehealth, may allow clinical pharmacists to collaboratively provide remote services without jeopardizing patient outcomes. Larger studies are needed to confirm these findings, and display the long-term impact and satisfaction of these services. ?Evaluation of virologic suppression rates during the COVID-19 pandemic(epmc).pdf DeepDyve Pubget Overpricing